Ana Belén
Herrero Hernández
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (2)
2017
-
Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair
Journal of Hematology and Oncology, Vol. 10, Núm. 1
2015
-
Deregulation of DNA double-strand break repair in multiple myeloma: Implications for genome stability
PLoS ONE, Vol. 10, Núm. 3